ZEO ScientifiX appoints Dr. Peter A.M. Everts as Chief Scientific and Technology Officer

Zeo ScientifiX, Inc.

Dr. Everts brings 35+ years of experience in orthobiology, spine, wound care, and regenerative medicine.
Previously CSO at EmCyte Corp and co-founder of Da Vinci Clinic, Netherlands; holds Ph.D. from University of Utrecht.
ZEO is a clinical-stage biopharmaceutical company focused on biological therapeutics for degenerative diseases.
Interim CEO Ian Bothwell says appointment underscores commitment to accelerating innovation and expanding regenerative therapies.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.